Annual Current Liabilities
$1.15 B
+$104.11 M+9.96%
March 31, 2024
Summary
- As of February 12, 2025, RDY annual total current liabilities is $1.15 billion, with the most recent change of +$104.11 million (+9.96%) on March 31, 2024.
- During the last 3 years, RDY annual current liabilities has risen by +$14.33 million (+1.26%).
- RDY annual current liabilities is now -12.28% below its all-time high of $1.31 billion, reached on March 31, 2017.
Performance
RDY Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.54 B
-$6.34 M-0.41%
December 31, 2024
Summary
- As of February 12, 2025, RDY quarterly total current liabilities is $1.54 billion, with the most recent change of -$6.34 million (-0.41%) on December 31, 2024.
- Over the past year, RDY quarterly current liabilities has increased by +$271.86 million (+21.47%).
- RDY quarterly current liabilities is now -0.41% below its all-time high of $1.54 billion, reached on September 30, 2024.
Performance
RDY Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RDY Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10.0% | +21.5% |
3 y3 years | +1.3% | +21.5% |
5 y5 years | +33.7% | +70.1% |
RDY Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -7.3% | +10.0% | -0.4% | +56.6% |
5 y | 5-year | -7.3% | +33.7% | -0.4% | +70.1% |
alltime | all time | -12.3% | +2276.5% | -0.4% | +3154.5% |
Dr Reddys Laboratories Limited Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $1.54 B(-0.4%) |
Sep 2024 | - | $1.54 B(+22.0%) |
Jun 2024 | - | $1.27 B(+10.0%) |
Mar 2024 | $1.15 B(+10.0%) | $1.15 B(+2.7%) |
Dec 2023 | - | $1.12 B(+10.8%) |
Sep 2023 | - | $1.01 B(+2.8%) |
Jun 2023 | - | $984.07 M(-5.9%) |
Mar 2023 | $1.05 B(-15.7%) | $1.05 B(+2.5%) |
Dec 2022 | - | $1.02 B(+3.8%) |
Sep 2022 | - | $982.22 M(-14.6%) |
Jun 2022 | - | $1.15 B(-7.2%) |
Mar 2022 | $1.24 B(+9.2%) | $1.24 B(+10.3%) |
Dec 2021 | - | $1.12 B(-2.8%) |
Sep 2021 | - | $1.16 B(-6.2%) |
Jun 2021 | - | $1.23 B(+8.5%) |
Mar 2021 | $1.14 B(+17.6%) | $1.14 B(+12.9%) |
Dec 2020 | - | $1.01 B(-5.2%) |
Sep 2020 | - | $1.06 B(+0.6%) |
Jun 2020 | - | $1.05 B(+9.2%) |
Mar 2020 | $965.44 M(+12.3%) | $965.44 M(+6.8%) |
Dec 2019 | - | $904.10 M(+4.2%) |
Sep 2019 | - | $867.54 M(-1.3%) |
Jun 2019 | - | $879.39 M(+2.3%) |
Mar 2019 | $859.62 M(-19.7%) | $859.62 M(-3.9%) |
Dec 2018 | - | $894.42 M(-9.0%) |
Sep 2018 | - | $983.24 M(-3.7%) |
Jun 2018 | - | $1.02 B(-4.6%) |
Mar 2018 | $1.07 B(-18.3%) | $1.07 B(-6.6%) |
Dec 2017 | - | $1.15 B(+6.5%) |
Sep 2017 | - | $1.08 B(+6.5%) |
Jun 2017 | - | $1.01 B(-22.9%) |
Mar 2017 | $1.31 B(+34.6%) | $1.31 B(-6.5%) |
Dec 2016 | - | $1.40 B(+4.8%) |
Sep 2016 | - | $1.34 B(+34.3%) |
Jun 2016 | - | $996.71 M(+2.4%) |
Mar 2016 | $973.57 M(-4.9%) | $973.57 M(+2.3%) |
Dec 2015 | - | $951.60 M(-4.2%) |
Sep 2015 | - | $993.50 M(-2.0%) |
Jun 2015 | - | $1.01 B(-0.9%) |
Mar 2015 | $1.02 B(+13.3%) | $1.02 B(+11.0%) |
Dec 2014 | - | $922.25 M(+3.8%) |
Sep 2014 | - | $888.86 M(+0.8%) |
Jun 2014 | - | $881.50 M(-2.4%) |
Mar 2014 | $903.39 M(-9.1%) | $903.39 M(-1.3%) |
Dec 2013 | - | $915.09 M(+4.7%) |
Sep 2013 | - | $874.16 M(-11.6%) |
Jun 2013 | - | $988.99 M(-0.5%) |
Mar 2013 | $994.19 M | $994.19 M(+9.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | $908.33 M(+1.3%) |
Sep 2012 | - | $896.43 M(+7.5%) |
Jun 2012 | - | $834.24 M(-1.4%) |
Mar 2012 | $846.17 M(-7.9%) | $846.17 M(-13.0%) |
Dec 2011 | - | $972.60 M(-7.7%) |
Sep 2011 | - | $1.05 B(+15.5%) |
Jun 2011 | - | $912.21 M(-0.7%) |
Mar 2011 | $918.74 M(+42.0%) | $918.74 M(+24.7%) |
Dec 2010 | - | $736.84 M(-0.1%) |
Sep 2010 | - | $737.77 M(+14.4%) |
Jun 2010 | - | $644.95 M(-0.3%) |
Mar 2010 | $646.90 M(+23.5%) | $646.90 M(+37.0%) |
Dec 2009 | - | $472.22 M(-6.0%) |
Sep 2009 | - | $502.10 M(+248.9%) |
Jun 2009 | - | $143.92 M(-72.5%) |
Mar 2009 | $523.89 M(+7.2%) | $523.89 M(-11.0%) |
Dec 2008 | - | $588.84 M(-4.6%) |
Sep 2008 | - | $617.21 M(+14.2%) |
Jun 2008 | - | $540.41 M(+10.6%) |
Mar 2008 | $488.65 M(+13.2%) | $488.65 M(+9.5%) |
Dec 2007 | - | $446.46 M(+4.0%) |
Sep 2007 | - | $429.38 M(+15.0%) |
Jun 2007 | - | $373.51 M(-13.5%) |
Mar 2007 | $431.59 M(+2.3%) | $431.59 M(-20.9%) |
Dec 2006 | - | $545.88 M(-7.3%) |
Sep 2006 | - | $588.78 M(+9.4%) |
Jun 2006 | - | $538.13 M(+27.5%) |
Mar 2006 | $422.06 M(+142.8%) | $422.06 M(+101.9%) |
Dec 2005 | - | $209.03 M(+0.9%) |
Sep 2005 | - | $207.07 M(+2.5%) |
Jun 2005 | - | $201.99 M(+16.2%) |
Mar 2005 | $173.86 M(+64.7%) | $173.86 M(+33.2%) |
Dec 2004 | - | $130.57 M(+4.0%) |
Sep 2004 | - | $125.50 M(-18.6%) |
Jun 2004 | - | $154.23 M(+46.1%) |
Mar 2004 | $105.59 M(+65.0%) | $105.59 M(+28.1%) |
Dec 2003 | - | $82.42 M(-1.7%) |
Sep 2003 | - | $83.86 M(+10.4%) |
Jun 2003 | - | $75.98 M(+18.8%) |
Mar 2003 | $63.98 M(+32.3%) | $63.98 M(+12.7%) |
Dec 2002 | - | $56.75 M(+6.0%) |
Sep 2002 | - | $53.52 M(-8.2%) |
Jun 2002 | - | $58.33 M(+20.6%) |
Mar 2002 | $48.38 M(-50.3%) | $48.38 M(+2.4%) |
Dec 2001 | - | $47.26 M(-6.3%) |
Sep 2001 | - | $50.44 M(-16.0%) |
Jun 2001 | - | $60.05 M |
Mar 2001 | $97.26 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual total current liabilities?
- What is the all time high annual current liabilities for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual current liabilities year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly current liabilities year-on-year change?
What is Dr Reddys Laboratories Limited annual total current liabilities?
The current annual current liabilities of RDY is $1.15 B
What is the all time high annual current liabilities for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual total current liabilities is $1.31 B
What is Dr Reddys Laboratories Limited annual current liabilities year-on-year change?
Over the past year, RDY annual total current liabilities has changed by +$104.11 M (+9.96%)
What is Dr Reddys Laboratories Limited quarterly total current liabilities?
The current quarterly current liabilities of RDY is $1.54 B
What is the all time high quarterly current liabilities for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly total current liabilities is $1.54 B
What is Dr Reddys Laboratories Limited quarterly current liabilities year-on-year change?
Over the past year, RDY quarterly total current liabilities has changed by +$271.86 M (+21.47%)